LATE PCR Partnership programme
LATE PCR expands the boundaries of what is possible with PCR. Bio-Seeq takes that capability out of the laboratory and opens up the possibility of powerful ‘near patient’ or ‘in the field’ diagnostics.
We are keen to make these technologies widely available and a number of partnership and sub-license opportunities will be made available.
At this time we are particularly keen to talk to companies wishing to develop assays, or indeed convert existing assays to run on the Bio-Seeq platform in animal health or human clinical diagnostics. Additionally LATE-PCR is available for sub-license on favourable terms to interested parties.
For more information about this program, please contact Dr John Czajka via the contact form.
We are keen to make these technologies widely available and a number of partnership and sub-license opportunities will be made available.
At this time we are particularly keen to talk to companies wishing to develop assays, or indeed convert existing assays to run on the Bio-Seeq platform in animal health or human clinical diagnostics. Additionally LATE-PCR is available for sub-license on favourable terms to interested parties.
For more information about this program, please contact Dr John Czajka via the contact form.
of a largely single stranded DNA product. The addition of this
logo to a product indicates the use, under licence, of a world leading technology.